• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠易激综合征亚型:临床与心理特征、体重指数及合并症

Irritable bowel syndrome subtypes: Clinical and psychological features, body mass index and comorbidities.

作者信息

Kibune Nagasako Cristiane, Garcia Montes Ciro, Silva Lorena Sônia Letícia, Mesquita Maria Aparecida

机构信息

Gastroenterology Unit, State University of Campinas, Brazil.

出版信息

Rev Esp Enferm Dig. 2016 Feb;108(2):59-64. doi: 10.17235/reed.2015.3979/2015.

DOI:10.17235/reed.2015.3979/2015
PMID:26838486
Abstract

BACKGROUND

Irritable bowel syndrome (IBS) is classified into subtypes according to bowel habit.

OBJECTIVE

To investigate whether there are differences in clinical features, comorbidities, anxiety, depression and body mass index (BMI) among IBS subtypes.

METHODS

The study group included 113 consecutive patients (mean age: 48 ± 11 years; females: 94) with the diagnosis of IBS. All of them answered a structured questionnaire for demographic and clinical data and underwent upper endoscopy. Anxiety and depression were assessed by the Hospital Anxiety and Depression scale (HAD).

RESULTS

The distribution of subtypes was: IBS-diarrhea (IBS-D), 46%; IBS-constipation (IBS-C), 32%, and mixed IBS (IBS-M), 22%. IBS overlap with gastroesophageal reflux disease (GERD), functional dyspepsia, chronic headache and fibromyalgia occurred in 65.5%, 48.7%, 40.7% and 22.1% of patients, respectively. Anxiety and/or depression were found in 81.5%. Comparisons among subgroups showed that bloating was significantly associated with IBS-M compared to IBS-D (odds ratio-OR-5.6). Straining was more likely to be reported by IBS-M (OR 15.3) and IBS-C (OR 12.0) compared to IBS-D patients, while urgency was associated with both IBS-M (OR 19.7) and IBS-D (OR 14.2) compared to IBS-C. In addition, IBS-M patients were more likely to present GERD than IBS-D (OR 6.7) and higher scores for anxiety than IBS-C patients (OR 1.2). BMI values did not differ between IBS-D and IBS-C.

CONCLUSION

IBS-M is characterized by symptoms frequently reported by both IBS-C (straining) and IBS-D (urgency), higher levels of anxiety, and high prevalence of comorbidities. These features should be considered in the clinical management of this subgroup.

摘要

背景

肠易激综合征(IBS)根据排便习惯分为不同亚型。

目的

研究IBS各亚型在临床特征、合并症、焦虑、抑郁及体重指数(BMI)方面是否存在差异。

方法

研究组纳入113例连续诊断为IBS的患者(平均年龄:48±11岁;女性94例)。所有患者均回答了关于人口统计学和临床数据的结构化问卷,并接受了上消化道内镜检查。焦虑和抑郁通过医院焦虑抑郁量表(HAD)进行评估。

结果

各亚型分布情况为:腹泻型肠易激综合征(IBS-D),46%;便秘型肠易激综合征(IBS-C),32%;混合型肠易激综合征(IBS-M),22%。IBS患者中,分别有65.5%、48.7%、40.7%和22.1%合并胃食管反流病(GERD)、功能性消化不良、慢性头痛和纤维肌痛。发现81.5%的患者存在焦虑和/或抑郁。亚组间比较显示,与IBS-D相比,腹胀与IBS-M显著相关(优势比-OR-5.6)。与IBS-D患者相比,IBS-M(OR 15.3)和IBS-C(OR 12.0)更易出现排便费力,而与IBS-C相比,便急与IBS-M(OR 19.7)和IBS-D(OR 14.2)均相关。此外,IBS-M患者比IBS-D患者更易出现GERD(OR 6.7),且焦虑得分高于IBS-C患者(OR 1.2)。IBS-D和IBS-C之间的BMI值无差异。

结论

IBS-M的特点是具有IBS-C(排便费力)和IBS-D(便急)常见的症状、更高水平的焦虑以及较高的合并症患病率。在该亚组的临床管理中应考虑这些特征。

相似文献

1
Irritable bowel syndrome subtypes: Clinical and psychological features, body mass index and comorbidities.肠易激综合征亚型:临床与心理特征、体重指数及合并症
Rev Esp Enferm Dig. 2016 Feb;108(2):59-64. doi: 10.17235/reed.2015.3979/2015.
2
Impact of concomitant dyspepsia and irritable bowel syndrome on symptom burden in patients with gastroesophageal reflux disease.胃食管反流病患者伴消化不良和肠易激综合征对症状负担的影响。
J Formos Med Assoc. 2019 Apr;118(4):797-806. doi: 10.1016/j.jfma.2018.12.002. Epub 2018 Dec 21.
3
Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea.便秘型或腹泻型肠易激综合征患者的上、下消化道症状重叠。
Am J Gastroenterol. 2003 Nov;98(11):2454-9. doi: 10.1111/j.1572-0241.2003.07699.x.
4
High-sensitive C-Reactive Protein as a Marker for Inflammation in Irritable Bowel Syndrome.高敏C反应蛋白作为肠易激综合征炎症标志物
J Clin Gastroenterol. 2016 Mar;50(3):227-32. doi: 10.1097/MCG.0000000000000327.
5
Patients with irritable bowel syndrome-diarrhea have lower disease-specific quality of life than irritable bowel syndrome-constipation.腹泻型肠易激综合征患者的疾病特异性生活质量低于便秘型肠易激综合征患者。
World J Gastroenterol. 2015 Jul 14;21(26):8103-9. doi: 10.3748/wjg.v21.i26.8103.
6
Dyspepsia and IBS symptoms in patients with NERD, ERD and Barrett's esophagus.非糜烂性反流病、糜烂性反流病和巴雷特食管患者的消化不良和肠易激综合征症状。
Dig Dis. 2008;26(3):243-7. doi: 10.1159/000121354. Epub 2008 May 7.
7
Irritable bowel syndrome: a comparison of subtypes.肠易激综合征:各亚型的比较
J Gastroenterol Hepatol. 2015 Feb;30(2):279-85. doi: 10.1111/jgh.12704.
8
Impact of coexisting irritable bowel syndrome and non-erosive reflux disease on postprandial abdominal fullness and sleep disorders in functional dyspepsia.并存的肠易激综合征和非糜烂性反流病对功能性消化不良患者餐后腹胀及睡眠障碍的影响
J Nippon Med Sch. 2013;80(5):362-70. doi: 10.1272/jnms.80.362.
9
Characterization of the alternating bowel habit subtype in patients with irritable bowel syndrome.肠易激综合征患者交替性排便习惯亚型的特征分析
Am J Gastroenterol. 2005 Apr;100(4):896-904. doi: 10.1111/j.1572-0241.2005.41211.x.
10
Clinical, metabolic, and psychological characteristics in patients with gastroesophageal reflux disease overlap with irritable bowel syndrome.胃食管反流病患者的临床、代谢和心理特征与肠易激综合征存在重叠。
Eur J Gastroenterol Hepatol. 2015 May;27(5):516-22. doi: 10.1097/MEG.0000000000000334.

引用本文的文献

1
Patient stratification reveals the molecular basis of disease co-occurrences.患者分层揭示了疾病共发的分子基础。
Proc Natl Acad Sci U S A. 2025 Sep 2;122(35):e2421060122. doi: 10.1073/pnas.2421060122. Epub 2025 Aug 29.
2
Exploring the relationship between irritable bowel syndrome and psychosocial, demographic, and health factors in Syrian hospital settings.探索叙利亚医院环境中肠易激综合征与心理社会、人口统计学和健康因素之间的关系。
BMC Psychiatry. 2025 Jul 16;25(1):708. doi: 10.1186/s12888-025-07138-y.
3
, a standardized herbal formula, promotes gastrointestinal motility via modulation of the acetylcholine pathway in a loperamide-induced functional dyspepsia mice.
一种标准化草药配方通过调节洛哌丁胺诱导的功能性消化不良小鼠的乙酰胆碱途径来促进胃肠动力。
Pharm Biol. 2025 Dec;63(1):218-228. doi: 10.1080/13880209.2025.2488134. Epub 2025 Apr 9.
4
Diet and gut microbial associations in irritable bowel syndrome according to disease subtype.根据疾病亚型探讨肠易激综合征的饮食与肠道微生物关联。
Gut Microbes. 2023 Dec;15(2):2262130. doi: 10.1080/19490976.2023.2262130. Epub 2023 Oct 2.
5
The Potential Role of Human Milk Oligosaccharides in Irritable Bowel Syndrome.人乳寡糖在肠易激综合征中的潜在作用
Microorganisms. 2022 Nov 25;10(12):2338. doi: 10.3390/microorganisms10122338.
6
H19 and TUG1 lncRNAs as Novel Biomarkers for Irritable Bowel Syndrome in Diabetic Patients.H19和TUG1长链非编码RNA作为糖尿病患者肠易激综合征的新型生物标志物
Biomedicines. 2022 Nov 19;10(11):2978. doi: 10.3390/biomedicines10112978.
7
Inhibition of TRPC4 channel activity in colonic myocytes by tricyclic antidepressants disrupts colonic motility causing constipation.三环类抗抑郁药抑制结肠肌细胞中的 TRPC4 通道活性,破坏结肠蠕动导致便秘。
J Cell Mol Med. 2022 Oct;26(19):4911-4923. doi: 10.1111/jcmm.17348. Epub 2022 May 12.
8
Immune responses in the irritable bowel syndromes: time to consider the small intestine.肠易激综合征的免疫反应:是时候考虑小肠了。
BMC Med. 2022 Mar 31;20(1):115. doi: 10.1186/s12916-022-02301-8.
9
Inflammation and Overlap of Irritable Bowel Syndrome and Functional Dyspepsia.肠易激综合征与功能性消化不良的炎症及重叠
J Neurogastroenterol Motil. 2021 Apr 30;27(2):153-164. doi: 10.5056/jnm20175.
10
Irritable bowel syndrome and Parkinson's disease risk: register-based studies.肠易激综合征与帕金森病风险:基于登记处的研究
NPJ Parkinsons Dis. 2021 Jan 5;7(1):5. doi: 10.1038/s41531-020-00145-8.